Cargando…

Clinical Characteristics of Mild Patients with Breakthrough Infection of Omicron Variant in China after Relaxing the Dynamic Zero COVID-19 Policy

For SARS-CoV-2 mutants, the effectiveness of the COVID-19 vaccines is still controversial. In this study, we aimed to investigate the clinical characteristics of Omicron-infected patients who completed primary immunization and booster immunization, respectively, during the rapid propagation of the O...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yingyu, Zhang, Fang, Liu, Yan, Xiong, Zhou, Zheng, Shangen, Liu, Wanbing, Liu, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224174/ https://www.ncbi.nlm.nih.gov/pubmed/37243072 http://dx.doi.org/10.3390/vaccines11050968

Ejemplares similares

Dynamic zero-COVID policy and healthcare utilization patterns in China during the Shanghai COVID-19 Omicron outbreak
por: Xiao, Hong, et al.
Publicado: (2023)

Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China
por: Li, Yanhua, et al.
Publicado: (2023)

‘Dynamic zero-COVID’ policy and viral clearance during an omicron wave in Tianjin, China: a city-wide retrospective observational study
por: Feng, Yahui, et al.
Publicado: (2022)

Optimizing the dynamic zero-COVID policy in China
por: Bai, Wei, et al.
Publicado: (2022)

Neutralization effect of plasma from vaccinated COVID-19 convalescents on SARS-CoV-2 Omicron variants
por: Xie, Yudi, et al.
Publicado: (2022)

Swift and extensive Omicron outbreak in China after sudden exit from ‘zero-COVID’ policy
por: Goldberg, Emma E., et al.
Publicado: (2023)

Forecast for peak infections in the second wave of the Omicron after the adjustment of zero-COVID policy in the mainland of China
por: Wang, Sheng-Tao, et al.
Publicado: (2023)

The Dynamic COVID-Zero Strategy in China
por: Liu, Jue, et al.
Publicado: (2022)

Assessment of vaccinations and breakthrough infections after adjustment of the dynamic zero-COVID-19 strategy in China: an online survey
por: Qin, Shijie, et al.
Publicado: (2023)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

A Small Surge in Incidence of SARS-CoV-2 Omicron Variant in the “Dynamic Zero” Period
por: Li, Xiaona, et al.
Publicado: (2023)

Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)
por: Barbui, Tiziano, et al.
Publicado: (2022)

SARS-CoV-2 omicron variant clearance delayed in breakthrough cases with elevated fasting blood glucose
por: Zhang, Xiujun, et al.
Publicado: (2022)

The COVID-19 pandemic in China: from dynamic zero-COVID to current policy
por: Ge, Junbo
Publicado: (2023)

Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees
por: Yu, Pei, et al.
Publicado: (2023)

Emergence of Omicron BA.1 and BA.2 variants and concern over vaccine breakthrough infection
por: Sukaina, Mahnoor, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
por: Keyel, Alexander C., et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
por: Regenhardt, Elisa, et al.
Publicado: (2023)

Omicron breakthrough infections in vaccinated or previously infected hamsters
por: Zhou, Jie, et al.
Publicado: (2023)

Efficacy and safety of molnupiravir in patients with Omicron variant vaccine breakthrough COVID-19 infection: a randomized, controlled trial
por: Liu, Yayun, et al.
Publicado: (2023)

Comparison of clinical characteristics between SARS-CoV-2 Omicron variant and Delta variant infections in China
por: Li, Qinggang, et al.
Publicado: (2022)

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022)

Immunological and metabolic characteristics of the Omicron variants infection
por: Geng, Jiejie, et al.
Publicado: (2023)

Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection
por: Guo, Yu, et al.
Publicado: (2023)

Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
por: YangYang, et al.
Publicado: (2022)

PB2578: ANTIBODY RESPONSE TO SARS-COV-2 OMICRON VARIANT IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER THE BREAKTHROUGH INFECTION WAVE IN CHONGQING, CHINA: A MULTI-CENTER, PROSPECTIVE STUDY
por: Jun, LI, et al.
Publicado: (2023)

Neurological Manifestations of hospitalized patients with mild to moderate infection with SARS-CoV-2 Omicron variant in Shanghai, China
por: Shen, Xiaolei, et al.
Publicado: (2023)

Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
por: Servellita, Venice, et al.
Publicado: (2022)

Breakthrough cases of Omicron and Delta variants of SARS-CoV-2 during the fifth wave in Pakistan
por: Jamal, Zunera, et al.
Publicado: (2022)

Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses
por: Zhou, Runhong, et al.
Publicado: (2022)

Multidimensional dynamic prediction model for hospitalized patients with the omicron variant in China
por: Chen, Yujie, et al.
Publicado: (2023)

Excess All-Cause Mortality in China After Ending the Zero COVID Policy
por: Xiao, Hong, et al.
Publicado: (2023)

Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
por: Jiang, Xiao-Lin, et al.
Publicado: (2023)

Dynamic zero COVID policy in the fight against COVID
por: Burki, Talha
Publicado: (2022)

Omicron breakthrough infections in patients with immune-mediated inflammatory diseases
por: Liew, Jean W, et al.
Publicado: (2022)

1467. Breakthrough Omicron Infections in Booster Vaccinated Healthcare Workers
por: Lee, Jeongjae, et al.
Publicado: (2022)

Will the zero-margin drug policy reduce the economic burden of stroke patients in China?
por: Fang, Quan, et al.
Publicado: (2021)

Species traits determined different responses to “zero-growth” policy in China’s marine fisheries
por: Kang, Bin, et al.
Publicado: (2022)

Clinical and upper airway characteristics of 3715 patients with the Omicron variant of SARS-Cov-2 in Changchun, China
por: Sha, Jichao, et al.
Publicado: (2023)

Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2
por: Yang, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s37do5j38epf00cn1262ob6mr9